BioCT welcomes Erika Smith to Board

BioCT is pleased to welcome Erika Smith to the Board of Directors.

Erika is the CEO of ReNetX Bio, a clinical stage, venture funded company in New Haven committed to advancing first-in-class, disease modifying therapy in the central nervous system. Over the past 25 years, Erika has held key executive roles at leading life-science including Respironics (Philips Healthcare), Hyperion and IVAX.

She also launched and led the advancement of three separate successful investment funds including the $25M Blavatnik Fund for Innovation at Yale, YEI Innovation Fund and the Bio-Life Fund at the Center for Innovative Technology in partnership with Johnson & Johnson.  more